US Stock MarketDetailed Quotes
HALO Halozyme Therapeutics
- 53.760
- +2.570+5.02%
Close Jan 8 16:00 ET
- 53.500
- -0.260-0.48%
Post 17:22 ET
6.84BMarket Cap17.80P/E (TTM)
55.000High51.910Low2.67MVolume54.120Open51.190Pre Close142.08MTurnover2.12%Turnover Ratio25.60P/E (Static)127.23MShares65.53352wk High15.11P/B6.77BFloat Cap33.15052wk Low--Dividend TTM125.91MShs Float65.533Historical High--Div YieldTTM6.04%Amplitude1.410Historical Low53.247Avg Price1Lot Size
Halozyme Therapeutics Stock Analyst Ratings & Price Target
Price Target
Updated: Jan 8, 2025
The average Halozyme Therapeutics stock price target is 65.60 with a max estimate of 73.00 and a min estimate of 55.00
Review Halozyme Therapeutics earnings estimates
Detailed Ratings
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Download APP
Analyst Ratings Disclaimer
Analysis
Price Target
Updated: Jan 8, 2025
Heat List
US
Overall
Symbol
Price
% Chg
No Data